FDA Drug Application (090719) for LEVONEST by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090719
Product Number001
FormTABLET;ORAL-28
Dosage0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVONEST
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by NOVAST LABS LTD